Nomura VIP Science and Technology Series
Ivy Variable Insurance Portfolios
Expense ratio
Net assets1
$781.05M
Holdings1
38
Category
US Equity
Return

Investment objective & strategy

As of April 29, 2025 · prospectus

Objective. Macquarie VIP Science and Technology Series seeks to provide growth of capital.

Strategy. Macquarie VIP Science and Technology Series invests primarily in the equity securities of science and technology companies around the globe. Under normal circumstances, the Series invests at least 80% of its net assets in securities of science or technology companies. Such companies may include companies that, in the opinion of Delaware Management Company (Manager), the Series investment manager, derive a competitive advantage by the application of scientific or technological developments or discoveries to grow their business or increase their competitive advantage. Science and technology companies are companies whose products, processes or services, in the opinion of the Manager, are being, or are expected to be, significantly benefited by the use or commercial application of scientific or technological developments or discoveries. … Macquarie VIP Science and Technology Series invests primarily in the equity securities of science and technology companies around the globe. Under normal circumstances, the Series invests at least 80% of its net assets in securities of science or technology companies. Such companies may include companies that, in the opinion of Delaware Management Company (Manager), the Series investment manager, derive a competitive advantage by the application of scientific or technological developments or discoveries to grow their business or increase their competitive advantage. Science and technology companies are companies whose products, processes or services, in the opinion of the Manager, are being, or are expected to be, significantly benefited by the use or commercial application of scientific or technological developments or discoveries. The Series also may invest in companies that utilize science and/or technology as an agent of change to significantly enhance their business opportunities (applied science and technology companies). The Series may invest in securities issued by companies of any size, and may invest without limitation in foreign securities, including securities of issuers within emerging markets. The Series is nondiversified , meaning that it may invest a significant portion of its total assets in a limited number of issuers. The Manager typically emphasizes growth potential in selecting stocks; that is, the Manager seeks companies in which earnings are likely to grow faster than the economy. The Manager aims to identify strong secular trends within industries and then applies a largely bottom-up (researching individual issuers) stock selection process by considering a number of factors in selecting securities for the Series. These may include but are not limited to a Series summary companys growth potential, earnings potential, quality of management, valuation, financial statements, industry position/market size potential and applicable economic and market conditions, as well as whether a companys products and services have high barriers to entry. The Series typically holds a limited number of stocks (generally 35 to 60). Many of the companies in which the Series may invest have diverse operations, with products or services in foreign markets. Therefore, the Series may have indirect exposure to various foreign markets through investments in these companies, even if the Series is not invested directly in such markets. Generally, in determining whether to sell a security, the Manager uses the same type of analysis that it uses in buying securities in order to determine whether the security has ceased to offer significant growth potential, has become overvalued and/or whether the company prospects of the issuer have deteriorated due to a change in management, change in strategy and/or a change in its financial characteristics. The Manager also may sell a security to reduce the Series holding in that security, to take advantage of what it believes are more attractive investment opportunities, when a securitys valuation reaches the Managers fair value targets, or to raise cash. The Manager may permit its affiliate, Macquarie Investment Management Global Limited (MIMGL), to execute Series security trades on behalf of the Manager. The Manager may also seek quantitative support from MIMGL.

Top holdings

As of March 31, 2026 · N-PORT
SecurityTickerValue% of fund
NVIDIA CORP $62.86M 8.05%
SEAGATE TECHNOLOGY HOLDINGS PLC $56.82M 7.28%
TAIWAN SEMIC MFG CO LTD SP ADR $46.64M 5.97%
LAM RESEARCH CORP $39.71M 5.08%
META PLATFORMS INC CL A $35.24M 4.51%
AMAZON.COM INC $33.06M 4.23%
BROADCOM INC $32.25M 4.13%
MICROSOFT CORP $31.26M 4.00%
ADV MICRO DEVICE $30.25M 3.87%
TEXAS INSTRUMENTS INC $27.71M 3.55%
View all holdings →

Allocation by sector

As of March 31, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Dec 31, 2025 → Mar 31, 2026
Opened
4
Exited
8
Increased
4
Decreased
26
Unchanged
4

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight
FundOverlapNet exp.
Nomura Science and Technology Fund · WSTRX, WSTAX, WSTCX, WSTYX, ISTIX, ISTNX 100% 0.84%
Nomura Transformational Technologies ETF · FRWD 80% 0.65%
Nationwide Bailard Technology & Science Fund · NWHOX, NWHPX, NWHQX, NWHTX, NWHUX 51% 0.68%
View all similar funds →

Advisers

As of December 31, 2025 · N-CEN
FirmRole
Macquarie Investment Management Business Trust Adviser

Footnotes

  1. Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.